U.S. Gas Utilities Stock News

NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Why RUM Group (RUM) Is Up 13.6% After Announcing A $13.7 Billion AI GPU Deal

Earlier this month, RUM Group Inc. announced a six-year, approximately US$13.70 billion agreement to provide GPU services and AI chip infrastructure to an unnamed U.S.-based cloud customer from its under-development Maysville, Georgia facility, alongside warrants for the customer to purchase over 50 million Class A shares. An important angle for investors is that RUM Group currently lacks the financing to deliver on this very large contract, meaning the agreement’s value is closely tied to...
NYSE:AGCO
NYSE:AGCOMachinery

Is AGCO (AGCO) Below Fair Value On Its Farm Progress Show Product Reveal?

AGCO’s Farm Progress Show reveal puts new equipment in focus AGCO (AGCO) is drawing fresh attention after announcing a wide slate of new tractors, planters and precision retrofit solutions for its Fendt, Massey Ferguson and PTx brands ahead of the 2026 Farm Progress Show. See our latest analysis for AGCO. AGCO’s Farm Progress Show plans come as the stock has seen a mixed pattern, with the 7 day share price return of 10.41% and the 30 day share price return down 9.14%, while the 1 year total...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

HealthEquity (HQY) Is Getting Attention, So What Is The Market Watching?

Analysts expect HealthEquity (HQY) to report quarterly earnings of $1.19 per share and revenue of $350.23 million in its upcoming release, with projections indicating growth in custodial revenue and total HSA assets. See our latest analysis for HealthEquity. HealthEquity’s recent momentum has been firm, with a 30-day share price return of 11.38% and a 90-day share price return of 20.80%. The 1-year total shareholder return of 20.57% highlights how expectations around earnings and HSA growth...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

NeoGenomics, Inc. previously announced that Alicia Olivo, EVP, General Counsel & Business Development, would step down as General Counsel in September 2026 and remain with the company until early October 2026 to support the transition. The company also secured a favorable North Carolina court ruling that invalidated key Natera patents, reducing legal friction around its RaDaR ST assay and altering the competitive landscape in molecular residual disease testing. We’ll now examine how this...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

CDW (CDW) Stock May Trade Below Fair Value After A 33% Fall

CDW stock has fallen about 33.0% over the past three years, yet the current share price of US$132.51 still screens as cheap on both an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and on earnings based multiples. That combination of weak recent returns and supportive valuation signals is what investors are weighing today. CDW's share price has declined 33.0% over three years, which puts the focus on whether the market has become too pessimistic about the company’s...
NYSE:RDW
NYSE:RDWAerospace & Defense

GE Aerospace Stock And 2 Defense Picks For Energy Sensitive Inflation

Energy sensitive inflation is back in focus as oil and gas prices feed into policy debates and consumer budgets. That spotlight on security and supply puts Aerospace and Defense stocks on many watchlists, since governments tend to treat defense and critical infrastructure as priority spending. This article explains why that theme matters now and highlights 3 Aerospace and Defense screener picks worth a closer look. The 3 Aerospace and Defense stocks below are just a sample. The full screen...
NYSE:AVY
NYSE:AVYPackaging

Avery Dennison (AVY) In Focus Following Board Chair Change And A Fair Value Debate

Avery Dennison (AVY) has drawn fresh attention after the Board elected William Wagner as independent Board Chair, effective September 1, 2026. This marks a planned shift in its long term leadership structure. See our latest analysis for Avery Dennison. The recent Board succession news lands after a period where Avery Dennison’s share price has gained momentum, with a 7 day share price return of 4.0% and a 30 day share price return of 14.16%, while the 1 year total shareholder return of 6.87%...
NYSE:GM
NYSE:GMAuto

How Investors Are Reacting To General Motors (GM) Canada Tariff Threats And New Labor Peace

Earlier in August 2026, Unifor reached tentative three-year labour agreements with General Motors covering more than 4,600 workers across key Canadian plants, while U.S.–Canada tensions intensified after President Trump announced plans for 50% tariffs on Canadian auto and parts imports starting January 1, 2027. At the same time, GM’s role in backing EVgo’s expanding fast‑charging network highlights how its long-term EV infrastructure commitments sit alongside rising cost uncertainty from...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (MELI) Tests Its Brazil Growth Story As Fair Value Debate Heats Up

MercadoLibre (MELI) is back in focus after reporting a 39% year over year jump in Brazil gross merchandise volume, driven by stronger buyer engagement, more active sellers, and user growth tied to free shipping and payment incentives. See our latest analysis for MercadoLibre. At a share price of $1,947.90, MercadoLibre has seen strong short term momentum with a 7 day share price return of 8.97% and a 90 day share price return of 18.19%. The 1 year total shareholder return is down 19.10% but...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

Immunome (IMNM) Reports A Wider Loss, Is The Premium Valuation Justified?

Immunome (IMNM) reported second quarter 2026 results that showed a wider loss, which may be influencing how investors view the stock following the announcement earlier in August 2026. See our latest analysis for Immunome. At a share price of US$28.01, Immunome has seen a 26.11% 1-month share price return and a 34.53% year-to-date share price return, alongside a 1-year total shareholder return of 182.36%. This suggests that recent earnings news is being weighed against a much stronger...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

Is Fannie Mae’s Executive Shake-Up And Holding-Company Idea Altering The Investment Case For FNMA?

In recent days, Fannie Mae has seen another wave of senior executive departures and cut about a dozen top leaders, while a white paper from Oksenholt Capital Management proposed a new public holding company that would sit above both Fannie Mae and Freddie Mac to capture operational and technology synergies. These management changes and structural proposals raise fresh questions about executive stability, multifamily financing capacity, and how Fannie Mae’s federal charter might be positioned...
NYSE:BIRK
NYSE:BIRKLuxury

Birkenstock Holding (BIRK), What Is Behind The Fresh Attention?

Birkenstock Holding (BIRK) moved back into focus after reporting stronger third quarter revenues, raising full-year revenue and adjusted EBITDA guidance, and pairing those updates with an accelerated share repurchase program. See our latest analysis for Birkenstock Holding. Despite the improved guidance and active capital management, Birkenstock Holding’s recent share price return has been weak, with the stock down 13.12% over 30 days and the 1 year total shareholder return declining 32.94%,...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

IPG Photonics (IPGP) On Defense And Medical Growth Narrative Is Valuation Too Cheap

IPG Photonics (IPGP) has drawn fresh attention after a recent pullback in its share price, with the stock closing at $70.74. Investors are reassessing the laser specialist as its recent returns show persistent weakness. See our latest analysis for IPG Photonics. The recent 1 day share price return of down 3.44% extends a sharp reset, with the 30 day share price return down 22.86% and the 1 year total shareholder return down 13.43%. This points to fading momentum as investors reassess IPG...
NasdaqGS:CAKE
NasdaqGS:CAKEHospitality

Why Cheesecake Factory (CAKE) Is Up 5.1% After Analysts Lift Full-Year Earnings Outlook - And What's Next

Earlier this year, Cheesecake Factory gained a Zacks Rank of #1 (Strong Buy) as analysts raised full‑year earnings estimates by 11.6%, signaling stronger expected profitability. What stands out is how rapidly improving analyst sentiment and upgraded earnings forecasts have repositioned Cheesecake Factory within the Retail‑Wholesale group. We’ll now explore how this upgraded analyst outlook, including higher full‑year earnings estimates, could reshape Cheesecake Factory’s investment...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Wins FDA Approval In First Line HER2 Positive GEA

BeOne Medicines (NasdaqGS:ONC) received FDA approval for TEVIMBRA (tislelizumab) plus ZIIHERA (zanidatamab) and chemotherapy as a first-line treatment for unresectable or metastatic HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma. The newly approved regimen is described as the first and only immunotherapy-based option to deliver more than two years of median overall survival in first-line HER2+ GEA. This decision adds a new US indication for BeOne Medicines and...
NYSE:FHI
NYSE:FHICapital Markets

How Investors May Respond To Federated Hermes (FHI) Zacks Rank Upgrade On Rising Earnings Estimates

Earlier in August 2026, Federated Hermes was upgraded to a Zacks Rank #1 (Strong Buy) after analysts raised earnings estimates, reflecting stronger expectations for its underlying business performance. This shift in analyst sentiment highlights how earnings estimate revisions can quickly reshape perceptions of an asset manager’s prospects relative to peers. Now we’ll examine how this upgrade, driven by rising earnings estimates, affects Federated Hermes’ existing investment narrative and...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

ACI Worldwide (ACIW) Following Inter Pag Win Looks Cheap Against Fair Value Narrative

Inter Pag deal puts ACI Worldwide in focus for Brazil’s digital payments growth ACI Worldwide (ACIW) is back on investor radar after Inter Pag selected the ACI Acquiring Platform and RS2 powered back-office card management for its next phase of payments expansion in Brazil. The agreement ties ACI Worldwide more closely to one of Brazil’s large small business focused acquirers, at a time when Pix and other alternative methods are reshaping how local merchants accept and process payments. See...
NYSE:AEE
NYSE:AEEIntegrated Utilities

Ameren (AEE) Declares Quarterly Dividend, Is The Stock Still Undervalued?

Ameren dividend declaration and what it means for shareholders Ameren (AEE) has affirmed its income policy, with the board declaring a quarterly cash dividend of $0.75 per share, payable September 30, 2026, to shareholders of record on September 8, 2026. See our latest analysis for Ameren. Ameren shares trade at $107.16, with a 1-day share price return of 0.97% and a year-to-date share price return of 6.25%. The 3-year total shareholder return of 46.36% points to stronger longer term...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave (CRWV) Lands Multi Year AI Cloud Deal With A Trading Firm

CoreWeave (NasdaqGS:CRWV) expanded its AI cloud ecosystem, becoming a key infrastructure provider within Rescale's digital engineering cloud for next generation R&D. The company also entered a multi year agreement with Hudson River Trading to supply AI cloud resources for quantitative trading research. These partnerships connect CoreWeave to demanding AI and high performance computing workloads across both engineering and financial markets. For readers looking to explore more companies...
NYSE:TPR
NYSE:TPRLuxury

Tapestry (TPR) Could Be 21% Below Fair Value After Profit Jump And 16% Dividend Hike

Tapestry (TPR) stock is in focus after the company reported fourth quarter and full year results, which showed higher sales and a swing to profit, alongside a 16% dividend increase and completion of a large buyback. See our latest analysis for Tapestry. The recent earnings, dividend increase and completed buyback have kept Tapestry in focus, with the 1 day share price return of 1.53% lifting the stock to US$132.16 even as the 30 day share price return is down 7.32%. That sits against a 1 year...
NYSE:YSS
NYSE:YSSAerospace & Defense

Space Stocks Retail Investors Are Watching After SpaceX’s $100 Billion Louisiana Launch Hub

SpaceX’s plan to pour up to US$100b into a new Starship launch hub in Louisiana has suddenly made space infrastructure feel much more real for investors. A project built around thousands of potential launches and 10,000 jobs can ripple across suppliers, satellite operators and ground systems. This article explores three stocks that appear positively tied to that story so you can judge where the opportunity or risk might sit for your portfolio. The three stocks in this article are just a...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

What Could GE HealthCare Technologies (GEHC) Gain From Its New CFO?

GE HealthCare Technologies (NasdaqGS:GEHC) named William K. Grogan as its next Chief Financial Officer, effective 14 September 2026. Grogan previously held senior finance roles at Xylem Inc. and IDEX Corporation, where he oversaw portfolio repositioning and large acquisition integrations. The CFO transition represents a key leadership shift for GE HealthCare, with potential implications for capital deployment and operational efficiency. For readers interested in more ideas in this area, the...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is Amgen (AMGN) Refocusing Its R&D Portfolio With The Exit From TScan’s Crohn’s Deal?

In August 2026, TScan Therapeutics disclosed that Amgen elected to terminate their May 2023 Research Collaboration and License Agreement focused on Crohn's disease, effective November 10, 2026, with no early termination penalty and the wind-down of current research activities. The move ends Amgen's exclusive rights to develop and commercialize any Crohn's disease product candidates from TScan's T-cell target discovery platform, removing potential success-based milestones of over US$500.00...
NasdaqGS:BANR
NasdaqGS:BANRBanks

Banner (BANR) Faces A Valuation Test After Its Pullback

Banner (BANR) has drawn attention after recent share price moves, with the stock edging down around 0.4% in the latest session and roughly 3.8% over the past week on modest trading interest. See our latest analysis for Banner. At a share price of $70.82, Banner has seen short term share price momentum cool after a weekly decline. However, its year to date share price return of 13.37% and 3 year total shareholder return of 79.77% still point to a stronger longer term record. If Banner's move...